| 摘要 |
FIELD: medicine.SUBSTANCE: invention represents a method of treating obliterating arterial sclerosis of the lower extremities combined with the ischemic heart disease involving administering drug preparations into a patient's body; the method is characterised by the fact that ozonised perftoran 200 ml is administered sequentially intravenously once a day, every second day, in a number of three infusions in a combination with oral administration of carvedilol 25 mg a day twice and rosuvastatin 10 mg once a day; if the patient shows high tolerability, a dose of carvedilol is increased to 50 mg, while a dose of rosuvastatin - to 20 mg a day for 12 days within the therapeutic course.EFFECT: invention provides the recovery of central, peripheral and coronary blood circulation in the involved extremity tissues and the cardiac muscle over a short period of time by activating the enzyme NO-oxidase, reducing an ability of thrombocytes to aggregation and increasing a percentage of high-density lipoproteins, reducing a percentage of low-density lipoproteins and adjusting the systemic atherosclerotic process in arterial walls of greater and smaller diameters.1 ex |
